Skip to content
★ Sign in to follow
PL

Pulsenmore Ltd. Stock: price and insider trades · United States

US·Mcap US$10.7MHealth Care

1 insider bought €14k of shares over the last 90 days, the latest by Sonnenschein Elazar, filed 05 Nov 2026.

Pulsenmore Ltd.: what insiders have been doing

Pulsenmore Ltd. belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). In the past year (5 November 2025 to 5 November 2026), 2 filings came from 2 insiders.

The flow runs one way only: 1 insider bought (1 purchase totalling €14k) and nobody sold on the market. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 chief executive. One trade stands out by size: a purchase of €14k from Sonnenschein Elazar, disclosed on 5 November 2026.

With 2 filings in twelve months, the company is quieter than the median of 24 filings across the 3,179 companies we follow on the same exchange. The full history, which starts in 2026, counts 1 purchase against no sales.

The most recent open-market purchase was published on 5 November 2026, 3 days ago.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Insider Decl.
2
Thresholds
n/a
Buy Volume
€13,976
1 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Elazar Sonnenschein1 buy

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 25,109 of 26,897 companies
17.8
score / 100
Value
1
Quality
35
FCF yld·
Earn yld-161%
EV/EBITDA·
ROE-45%
Gross mgn84%
Net mgn-40%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$1.64
Analyst consensus
·
Income statement
RevenueUS$40M
Gross profitUS$33.7M84% margin
EBITDA-US$12.7M-32% margin
Net income-US$15.9M-65.9% margin
Valuation
Beta0.44
Balance sheet & cash
Market capUS$10.7M
Total debtUS$1.6M
Free Cash Flow-US$33M
Debt / Equity2%
Profitability & ownership
ROE-45.2%
ROA-7.0%
% insiders35.8%
% institutions4.5%
Last declaration on 5 November 2026
Declarations2 total
  • ▲
    Chief Executive OfficerExecutives
    15,740 USD0SEC
    9,259 shares@ US$1.70Ordinary SharesSEC:0001493152-26-050241:0
    Canonical exit: 2 Feb 2027 (T+90)
  • ◇
    DirectorExecutives
    1,500 USD19SEC
    46,874 shares@ US$0.032100.0% of flowOrdinary SharesSEC:0001493152-26-047022:0

2 of 2 declarations

About Pulsenmore Ltd.

Pulsenmore Ltd. is a company focused on developing digital health solutions. It specializes in providing innovative medical devices for remote patient monitoring.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations